Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,318 | 17,382 | 13,250 | 8,672 | 5,063 |
| Depreciation Amortization | 291 | 785 | 586 | 391 | 195 |
| Accounts receivable | -3,412 | -756 | 506 | -656 | 2,037 |
| Accounts payable and accrued liabilities | 2,481 | 2,270 | 4,216 | 5,154 | 2,106 |
| Other Working Capital | -5,119 | -8,296 | -4,627 | -1,623 | 2,681 |
| Other Operating Activity | -1,753 | 2,119 | -1,106 | -2,805 | -4,199 |
| Operating Cash Flow | $-1,194 | $13,504 | $12,825 | $9,133 | $7,883 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 5,739 | -292 | -191 | -167 | -32 |
| Other Investing Activity | -494 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $5,245 | $-292 | $-191 | $-167 | $-32 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 111 | 7,246 | 7,018 | 6,866 | 3,114 |
| Common Stock Repurchased | -2,354 | -251 | N/A | N/A | N/A |
| Other Financing Activity | -47 | -79 | -22 | -18 | -9 |
| Financing Cash Flow | $-2,290 | $6,916 | $6,996 | $6,848 | $3,105 |
| Beginning Cash Position | 64,788 | 44,660 | 44,660 | 44,660 | 44,660 |
| End Cash Position | 66,549 | 64,788 | 64,290 | 60,474 | 55,616 |
| Net Cash Flow | $1,761 | $20,128 | $19,630 | $15,814 | $10,956 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,194 | 13,504 | 12,825 | 9,133 | 7,883 |
| Capital Expenditure | -61 | -292 | -191 | -167 | -32 |
| Free Cash Flow | -1,255 | 13,212 | 12,634 | 8,966 | 7,851 |